Science Sparks @ ACTREC
.
26th May 2025Publications
- 1. Hasan SK, Jayakumar S, Espina Barroso E, Jha A, Catalano G, Sandur SK, Noguera NI (2025). Molecular targets of oxidative stress: Focus on nuclear factor erythroid 2–related factor 2 function in leukemia and other cancers. Cells. 14(10):713.
- 2. Joshi P, Bane S, Chaturvedi P, Gera P, Waghmare SK (2025). Establishment and characterization of patient-derived tongue squamous cell carcinoma cell lines. Human Cell. 38(4):102.
- 3. Anthony C, Harish M, Christie J, Venkatraman P (2025). Novel interaction with PSMD9 regulates DNAJA1 turnover and mitochondrial polarity. Biochemical and Biophysical Research Communications
- 4. Dasgupta A, Mani S, Chatterjee A, Kannan S, Moiyadi A, Shetty P, Singh V, Menon N, Sahu A, Choudhary A, Bhattacharya K, Puranik A, Dev I, Epari S, Sahay A, Shah A, Bano N, Shaikh F, Gupta T (2025). Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial. BMC Cancer. 25(1):911.
- 5. Murthy V, Samanta A, Maitre P, Nayak P, Singh P, Agrawal A, Joshi A, Prakash G (2025). Abiraterone for "STAMPEDE-Like" cohort of high-risk prostate cancer in the PSMA-PET era: too much, too early? Prostate Cancer and Prostatic Diseases.
- 6. Mirgh S, Yanamandra U, Vishvanathan G, Gundeti S, Khattry N, John M, Malhotra P, Menon H, Das B, Nair R, Nair V, Saikia T, Kumar S (2025). Clinical perspectives on amyloidosis in India: A systematic literature review. Clinical Lymphoma Myeloma and Leukemia.
- 7. Ghosh -Laskar S, Sood S, Chatterjeec A, Sinha S, Sharma S, Chaukar D, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Swain M, Kumar A, Mohanty S, Chaturvedi P, Pai P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Tuljapurkar V, Deshpande M, Joshi A, Noronha V, Prabhash K, D'cruz A. (2025) Presentation and outcomes of second primary malignancies (SPMs) in locally advanced oral cavity squamous carcinoma (LA-OSCC): Secondary analysis of a phase III randomised control trial (NCT00193843). Radiotherapy and Oncology.
Video of the Week
.png)
Genomic Insights into Colon Cancer Research
Upcoming Events
June 21, 2025
At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai
June 26-28, 2025
At ACTREC, Tata Memorial Centre, Kharghar , Navi Mumbai.
Do You Know?
In 1945, Felix Bloch and Edward Purcell discovered nuclear magnetic resonance which is used to detect brain tumors and other cancers.
Cancer News
MedicalXpress, 22/05/2025
Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development. Researchers have now shown how a protein that controls the development of the arms and heart contributes to making colorectal cancer cells more aggressive and likely to spread...
Eurekalert, 23/05/2025
The researchers found that 6-OHDA treatment in human cervical carcinoma cells induced a dose-dependent increase in PARK7 secretion. Notably, this increase was unaffected by blocking the conventional ER-to-Golgi trafficking protein pathway and the exosomal release pathway...
Eurekalert, 21/05/2025
A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing cancer cells from repairing themselves...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)